Graphite Bio co-founder de­buts Treg cell ther­a­py start­up with $75M, aims to ‘trick’ im­mune sys­tem in­to re­set­ting

Tr1x launched from stealth Wednes­day with $75 mil­lion to tack­le graft-ver­sus-host dis­ease in ad­di­tion to in­flam­ma­to­ry and au­toim­mune con­di­tions.

The biotech was cre­at­ed by Maria …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER